Inventor · disambiguated record
Tarlochan S. Nijjar
Also filed as: NIJJAR TARLOCHAN · NIJJAR TARLOCHAN S
48 granted patents·20 pending applications·313 citations·filing 2012–2025
98Inventor score
Files withPROTHENA BIOSCIENCES LTD40OTHAIR PROTHENA LTD13NEOTOPE BIOSCIENCES LTD5NOVO NORDISK AS4BARBOUR ROBINOO1
Top patents by PatentIndex Score
68 records- 0197US11912759B2Anti-transthyretin antibodiesNOVO NORDISK AS·Filed 2021·Granted Feb 27, 2024·4 cites·20 claims
- 0297US10961302B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Mar 30, 2021·7 cites·38 claims
- 0397US9884906B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Feb 6, 2018·12 cites·20 claims
- 0497US8609820B2Humanized antibodies that recognize alpha-synucleinNEOTOPE BIOSCIENCES LTD·Filed 2012·Granted Dec 17, 2013·35 cites·16 claims
- 0596US11440953B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2022·Granted Sep 13, 2022·3 cites·19 claims
- 0696US11434283B2Anti-abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·3 cites·19 claims
- 0796US10633433B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Apr 28, 2020·9 cites·43 claims
- 0896US10464999B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Nov 5, 2019·11 cites·78 claims
- 0996US10450369B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Oct 22, 2019·7 cites·43 claims
- 1096US9670273B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2015·Granted Jun 6, 2017·15 cites·21 claims
- 1196US9556259B2Humanized antibodies that recognize alpha-synucleinNEOTOPE BIOSCIENCES LTD·Filed 2014·Granted Jan 31, 2017·15 cites·59 claims
- 1296US8790644B2Humanized antibodies that recognize alpha-synucleinNEOTOPE BIOSCIENCES LTD·Filed 2013·Granted Jul 29, 2014·28 cites·79 claims
- 1395US11965005B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 23, 2024·1 cites·25 claims
- 1495US11434285B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 1595US11434284B2Anti-Abeta antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Sep 6, 2022·2 cites·19 claims
- 1695US10669330B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Jun 2, 2020·8 cites·32 claims
- 1795US10118960B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Nov 6, 2018·12 cites·22 claims
- 1895US9234031B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Jan 12, 2016·17 cites·9 claims
- 1995US9217030B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 22, 2015·17 cites·82 claims
- 2094US11028158B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 8, 2021·6 cites·36 claims
- 2194US10906967B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Feb 2, 2021·6 cites·30 claims
- 2294US9879080B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Jan 30, 2018·13 cites·36 claims
- 2393US12479910B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Granted Nov 25, 2025·1 cites·21 claims
- 2493US10875909B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·17 claims
- 2593US10723792B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jul 28, 2020·3 cites·21 claims
- 2693US10081674B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Sep 25, 2018·18 cites·26 claims
- 2793US9605056B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2013·Granted Mar 28, 2017·22 cites·22 claims
- 2892US10494426B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Dec 3, 2019·9 cites·34 claims
- 2992US10301382B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 28, 2019·10 cites·20 claims
- 3090US12247056B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2024·Granted Mar 11, 2025·0 cites·26 claims
- 3190US10875910B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·12 claims
- 3290US10597441B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 24, 2020·4 cites·26 claims
- 3390US2025179161A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2024·Application pending·0 cites
- 3489US10669331B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 2, 2020·3 cites·22 claims
- 3588US11926659B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2021·Granted Mar 12, 2024·1 cites·32 claims
- 3687US11952406B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 9, 2024·0 cites·25 claims
- 3787US11945849B2Multi-epitope vaccine for the treatment of Alzheimer's diseaseOTHAIR PROTHENA LTD·Filed 2023·Granted Apr 2, 2024·0 cites·25 claims
- 3886US2024141025A1Anti-transthyretin antibodiesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 3982US2023331828A1Anti-Abeta AntibodiesOTHAIR PROTHENA LTD·Filed 2022·Application pending·0 cites
- 4081US12049498B2Humanized antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 4180US12049497B2Antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·9 claims
- 4280US2025282838A1Multi-Epitope Vaccine for the Treatment of Alzheimer's DiseaseOTHAIR PROTHENA LTD·Filed 2025·Application pending·0 cites
- 4379US11267877B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 8, 2022·1 cites·40 claims
- 4479US2024209073A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4578US11958896B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Apr 16, 2024·1 cites·22 claims
- 4678US8741298B2APOE immunotherapySCHENK DALE B·Filed 2012·Granted Jun 3, 2014·3 cites·65 claims
- 4777US12435129B2Anti-Aβ antibodiesOTHAIR PROTHENA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·14 claims
- 4876US2023183304A1Multi-Epitope Vaccine for the Treatment of Alzheimer's DiseaseBARBOUR ROBINOO·Filed 2021·Application pending·0 cites
- 4975US11629185B2Anti-transthyretin antibodiesNOVO NORDISK AS·Filed 2020·Granted Apr 18, 2023·0 cites·18 claims
- 5075US11345749B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted May 31, 2022·0 cites·5 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tarlochan S. Nijjar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →